Rachel Margolis-Goodman: When Conventional Treatment Could Not, Research Found an Answer
Rachel Margolis-Goodman, Director of Advancement for the Versiti Blood Research Institute, shared Versiti Inc.’s post on LinkedIn:
“Semi is alive today because research found an answer when conventional treatment could not.
After his bone marrow transplant, Semi’s body rejected every platelet transfusion. Researchers at the Versiti Blood Research Institute identified an exceptionally rare condition and the specialized platelet match that helped save his life.
This is the power of blood research.
If you believe every patient deserves access to lifesaving discoveries, I invite you to read Semi’s story and support the work of VBRI.”
Versiti Inc. shared a post on LinkedIn:
“A bone marrow transplant gave Semi a second chance. Research made sure he could receive it.
When 16-year-old Semi’s body rejected every platelet transfusion after his transplant, his care team turned to the Versiti Blood Research Institute for answers.
Researchers uncovered an exceptionally rare condition and identified the specialized platelet match that helped save his life.
It’s a powerful example of what becomes possible when researchers, laboratory experts, physicians and blood donors work together.
Read Semi and Temi’s inspiring story.
We’re grateful to Zizzo Group – Engagement Marketing for their partnership in bringing Semi and Temi’s story to life.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke